ChemoMetec Financial Statements From 2010 to 2024
| CHEMM Stock | DKK 480.00 0.40 0.08% |
Check ChemoMetec financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ChemoMetec's main balance sheet or income statement drivers, such as , as well as many indicators such as . ChemoMetec financial statements analysis is a perfect complement when working with ChemoMetec Valuation or Volatility modules.
ChemoMetec |
ChemoMetec AS Company Operating Margin Analysis
ChemoMetec's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current ChemoMetec Operating Margin | 0.50 % |
Most of ChemoMetec's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ChemoMetec AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, ChemoMetec AS has an Operating Margin of 0.5016%. This is 105.67% lower than that of the Life Sciences Tools & Services sector and 103.42% lower than that of the Health Care industry. The operating margin for all Denmark stocks is 109.1% lower than that of the firm.
ChemoMetec AS Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ChemoMetec's current stock value. Our valuation model uses many indicators to compare ChemoMetec value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ChemoMetec competition to find correlations between indicators driving ChemoMetec's intrinsic value. More Info.ChemoMetec AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.64 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ChemoMetec AS is roughly 1.56 . Comparative valuation analysis is a catch-all model that can be used if you cannot value ChemoMetec by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ChemoMetec's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About ChemoMetec Financial Statements
ChemoMetec stakeholders use historical fundamental indicators, such as ChemoMetec's revenue or net income, to determine how well the company is positioned to perform in the future. Although ChemoMetec investors may analyze each financial statement separately, they are all interrelated. For example, changes in ChemoMetec's assets and liabilities are reflected in the revenues and expenses on ChemoMetec's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ChemoMetec AS. Please read more on our technical analysis and fundamental analysis pages.
ChemoMetec AS engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company was founded in 1997 and is headquartered in Allerd, Denmark. ChemoMetec operates under Medical Equipment classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 155 people.
Pair Trading with ChemoMetec
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ChemoMetec position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChemoMetec will appreciate offsetting losses from the drop in the long position's value.Moving against ChemoMetec Stock
| 0.52 | CARL-A | Carlsberg AS | PairCorr |
| 0.52 | CARL-B | Carlsberg AS | PairCorr |
| 0.49 | JYSK | Jyske Bank AS | PairCorr |
| 0.42 | ORSTED | Orsted AS | PairCorr |
| 0.37 | GMAB | Genmab AS | PairCorr |
The ability to find closely correlated positions to ChemoMetec could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ChemoMetec when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ChemoMetec - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ChemoMetec AS to buy it.
The correlation of ChemoMetec is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ChemoMetec moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ChemoMetec AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ChemoMetec can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in ChemoMetec Stock
ChemoMetec financial ratios help investors to determine whether ChemoMetec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ChemoMetec with respect to the benefits of owning ChemoMetec security.